Dated 25 th June 2010
STRAKAN INTERNATIONAL LIMITED
CRAWFORD HEALTHCARE LIMITED
ACQUISITION AND LICENCE AGREEMENT
123 Deansgate Manchester M3 2BU
Tel 0161 909 3000 Fax 0161 909 4444
THIS AGREEMENT is dated 25 th June 2010
(1) STRAKAN INTERNATIONAL LIMITED a company incorporated in Bermuda and registered in
Scotland under company number F000906, whose registered office is at Galabank Business Park,
Galashiels, TD1 1QH ( Strakan );
(2) ULURU INC , a company incorporated in Nevada, whose registered office is at 4452 Beltway Drive,
Addison, Texas 75001, United States of America ( Uluru );
(3) ZINDACLIN LIMITED , a company registered in England with company number 7244532, whose
registered office is at Cheshire House, 164 Main Road, Goostrey, Crewe, Cheshire, CW4 8JP
( Zindaclin ); and
(4) CRAWFORD HEALTHCARE LIMITED , a company registered in England with company number
03262015, whose registered office is at Cheshire House, 164 Main Road, Goostrey, Crewe, Cheshire,
CW4 8JP ( Crawford ).
Zindaclin is a member of the same Group as Crawford.
Strakan is the registered proprietor of certain registered and unregistered trade marks for “Zindaclin”.
Pursuant to an agreement between Strakan and Crawford, dated 10 October 2005 and amended 8
December 2006 ( Existing Licence Agreement ) (a copy of which is appended to this agreement in
Appendix 3), Strakan granted a licence to Crawford to import, promote, market, use, distribute and sell
products under the Zindaclin trade marks in certain territories.
Pursuant to an agreement between Strakan and Access Pharmaceuticals, Inc ( Access ), dated 26 th
February 1998, as amended by ad